CD8A and type 1 diabetes mellitus: As HLA‐B*39 carries the strongest type 1 diabetes risk of all HLA class I gene polymorphisms, we sought to determine whether HLA‐B*39‐restricted CD8+ T cells with specificity for β cell antigens could be detected in individuals with type 1 diabetes.